
Daniel J. George, MD, Duke Cancer Center
Advertisement
Articles by Daniel J. George, MD, Duke Cancer Center
Advertisement
Latest Updated Articles
Tailored Therapy Approaches for Upfront mRCC TreatmentJuly 23rd 2020
Patient Factor Consideration for Treatment of mRCCJuly 23rd 2020
Future of Treating mRCCJuly 23rd 2020
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Neladalkib for Locally Advanced or Metastatic ALK+ NSCLC
2
FDA Removes Limitations of Use for Liso-Cel in Primary Central Nervous System Lymphoma
3
FDA Accepts sNDA for Selinexor Plus Ruxolitinib in Myelofibrosis
4
TCR-Based Strategies and Tolerable Combinations Begin to Narrow the Outcome Gap in Uveal Melanoma
5
















